We are live on ! Find out more
CCM

Chicago Capital Management Portfolio holdings

AUM $112M
1-Year Est. Return 76.54%
This Fund
S&P 500
This Quarter Est. Return
+17.46%
1 Year Est. Return
+76.54%
3 Year Est. Return
+294.65%
5 Year Est. Return
+1,991.46%
10 Year Est. Return
+177,846.73%
AUM
$136M
AUM Growth
-$24.9M
Cap. Flow
-$96M
Cap. Flow %
-70.53%
Top 10 Hldgs %
51.55%
Holding
51
New
11
Increased
1
Reduced
–
Closed
11

Top Buys

Rank Stock Value
1
SWTX
SpringWorks Therapeutics
SWTX
+$8.91M
2
OPOF
Old Point Financial
OPOF
+$7.18M
3
BPMC
Blueprint Medicines
BPMC
+$6.23M
4
VIGL
Vigil Neuroscience
VIGL
+$2.16M
5
PWOD
Penns Woods Bancorp
PWOD
+$1.8M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$11.9M
2
FNA
Paragon 28, Inc.
FNA
+$7.46M
3
CCRN
Cross Country Healthcare
CCRN
+$5.99M
4
PDCO
Patterson Companies, Inc.
PDCO
+$4.92M
5
EVBN
Evans Bancorp Inc
EVBN
+$4.44M

Sector Composition

Rank Sector Weight
1 Healthcare 16.42%
2 Financials 8.9%
3 Industrials 2.98%
4 Energy 0.51%
5 Technology 0.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SWTX
1
DELISTED
SpringWorks Therapeutics
SWTX
$9.41M 6.91%
+200,230
New +$8.91M
BPMC
2
DELISTED
Blueprint Medicines
BPMC
$7.69M 5.65%
+60,000
New +$6.23M
OPOF
3
DELISTED
Old Point Financial
OPOF
$7.27M 5.34%
+185,296
New +$7.18M
VIGL
4
DELISTED
Vigil Neuroscience
VIGL
$3.84M 2.82%
+482,769
New +$2.16M
PWOD
5
DELISTED
Penns Woods Bancorp
PWOD
$2.36M 1.73%
77,579
+62,661
+420% +$1.8M
TGI
6
DELISTED
Triumph Group
TGI
$2.19M 1.61%
85,000
– –
HPE.PRC
7
Hewlett Packard Enterprise 7.625% Series C Preferred Stock
HPE.PRC
$3.7B
$1.94M 1.42%
32,900
– –
SSBK
8
DELISTED
Southern States Bancshares
SSBK
$1.69M 1.24%
+46,451
New +$1.59M
GMS
9
DELISTED
GMS Inc
GMS
$1.63M 1.2%
+15,000
New +$1.16M
VERV
10
DELISTED
Verve Therapeutics
VERV
$1.41M 1.03%
+125,377
New +$715K
HES
11
DELISTED
Hess
HES
$693K 0.51%
5,000
– –
CTLP
12
DELISTED
Cantaloupe
CTLP
$557K 0.41%
+50,692
New +$439K
CFSB
13
DELISTED
CFSB Bancorp
CFSB
$478K 0.35%
+34,858
New +$369K
EBTC
14
DELISTED
Enterprise Bancorp
EBTC
$312K 0.23%
+7,859
New +$300K
NVEE
15
DELISTED
NV5 Global
NVEE
$231K 0.17%
+10,000
New +$200K
CCRN
16
DELISTED
Cross Country Healthcare
CCRN
– –
-402,000
Closed -$5.99M
EVBN
17
DELISTED
Evans Bancorp Inc
EVBN
– –
-113,873
Closed -$4.44M
FNA
18
DELISTED
Paragon 28, Inc.
FNA
– –
-571,300
Closed -$7.46M
CMRX
19
DELISTED
Chimerix, Inc.
CMRX
– –
-256,700
Closed -$2.18M
PDCO
20
DELISTED
Patterson Companies, Inc.
PDCO
– –
-157,615
Closed -$4.92M
PYCR
21
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
– –
-25,744
Closed -$578K
ACCD
22
DELISTED
Accolade Inc
ACCD
– –
-259,233
Closed -$1.81M
ITCI
23
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-90,200
Closed -$11.9M
SASR
24
DELISTED
Sandy Spring Bancorp Inc
SASR
– –
-25,000
Closed -$700K
VBFC
25
DELISTED
Village Bank and Trust Financial Corp.
VBFC
– –
-3,738
Closed -$300K
1
2

Similar funds

PC
Parrish Capital Kennesaw, Georgia $112M AUM
PFS
Professional Financial Solutions Falls Chruch, Virginia $112M AUM
VCM
Veradace Capital Management Dallas, Texas $112M AUM
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
AIC
Argus Investors Counsel New York $112M AUM 25.83% 1-Year Est. Return
APFP
Action Point Financial Planning Grand Rapids, Michigan $112M AUM
AIP
Arrowpoint Investment Partners Singapore $113M AUM 73.91% 1-Year Est. Return
MWP
Momentum Wealth Planning Estero, Florida $113M AUM 26.08% 1-Year Est. Return

Chicago Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Chicago Capital Management held 51 positions worth $136M, down 15% from $161M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Chicago Capital Management withdrew a net $96M in Q2 2025, closing 11 positions. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $11.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 20% a quarter earlier, followed by Financials and Industrials.

Against the trend, Chicago Capital Management opened a new position in SpringWorks Therapeutics worth $9.41M.

  • Chicago Capital Management's largest Q2 2025 buy was SpringWorks Therapeutics: 200,230 shares worth $9.41M.
  • Chicago Capital Management added most to Penns Woods Bancorp in Q2 2025, an estimated $1.8M increase.
  • Chicago Capital Management fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $11.9M.
  • Chicago Capital Management's ten largest holdings make up 52% of its $136M portfolio in Q2 2025.
  • Chicago Capital Management opened 11 new positions and closed 11 in Q2 2025.
  • Chicago Capital Management's portfolio value fell 15% quarter-over-quarter to $136M.

Based on Chicago Capital Management's 13F filing for Q2 2025, filed 7 Aug 2025.